ArticleFrontiers in immunology2021

Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy.

Luis Felipe Olguín-Contreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.